When was keytruda's first fda approval granted?

When did the FDA first approve Keytruda (pembrolizumab)?

Keytruda’s first FDA approval was granted on September 4, 2014. [1]

What was Keytruda’s first approval for?

That initial approval was for advanced melanoma (specifically, for patients with unresectable or metastatic melanoma whose disease had progressed after other treatments). [1]

Has the FDA approved Keytruda for more indications since then?

Yes. After the 2014 initial approval, the FDA expanded Keytruda’s use to additional cancer types and clinical settings over time. [1]

Sources

1